NCT02206620View on ClinicalTrials.gov

Effects of Cholinergic Augmentation on Measures of Balance and Gait

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Parkinson's Disease
Interventions
DRUG

Donepezil

Trial Locations (1)

97239-3098

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Oregon Health and Science University

OTHER

NCT02206620 - Effects of Cholinergic Augmentation on Measures of Balance and Gait | Biotech Hunter | Biotech Hunter